Legal Representation
Attorney
J. Charles Dougherty
USPTO Deadlines
Application History
46 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Aug 5, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Aug 5, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Jul 31, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Jul 30, 2025 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN | Loading... |
Jul 30, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Jul 30, 2025 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
Jul 22, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
Jul 22, 2025 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
Apr 7, 2025 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
Apr 7, 2025 | IUAF | S | USE AMENDMENT FILED | Loading... |
Sep 30, 2024 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
Sep 30, 2024 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
Sep 30, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Sep 30, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Apr 9, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Apr 4, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Apr 4, 2024 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
Apr 4, 2024 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
Jul 22, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jul 20, 2023 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
Jul 20, 2023 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
Jul 20, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Mar 15, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Mar 13, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Mar 13, 2023 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
Mar 13, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Nov 4, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Nov 4, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Nov 4, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Oct 7, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Oct 5, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Oct 5, 2022 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Oct 5, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Apr 5, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Feb 8, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Feb 8, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Jan 19, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Jan 5, 2022 | ALIE | A | ASSIGNED TO LIE | Loading... |
Jan 4, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Jan 4, 2022 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
Jan 4, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Jan 4, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Jan 4, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Dec 27, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Aug 3, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
May 1, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
administration of a discount program for enabling participants to obtain discounts on prescription drugs through the use of a discount membership card; administering discount purchasing programs, namely, negotiating contracts with pharmacies to enable participant members to obtain discounts on the purchase of prescription drugs through the use of membership cards
First Use Anywhere:
Dec 19, 2024
First Use in Commerce:
Dec 19, 2024
Classification
International Classes
035
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"RX"